You have 9 free searches left this month | for more free features.

Tosedostat

Showing 1 - 11 of 11

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome Trial in Houston (Azacitidine, Cytarabine, Tosedostat)

Terminated
  • Acute Myeloid Leukemia
  • High Risk Myelodysplastic Syndrome
  • Houston, Texas
    M D Anderson Cancer Center
Apr 9, 2020

Pancreatic Cancer, Cancer of Pancreas, Cancer of the Pancreas Trial in Saint Louis (Tosedostat, Capecitabine, Fresh tissue

Terminated
  • Pancreatic Cancer
  • +3 more
  • Tosedostat
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Aug 20, 2019

Myelodysplastic Syndrome Trial in New York (Tosedostat)

Completed
  • Myelodysplastic Syndrome
  • Tosedostat
  • New York, New York
    Weill Cornell Medical College
Jun 7, 2018

Acute Myeloid Leukemia With Multilineage Dysplasia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute

Completed
  • Acute Myeloid Leukemia With Multilineage Dysplasia
  • +8 more
  • tosedostat
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Feb 13, 2017

Acute Myeloid Leukemia, AML Trial in Canada, Netherlands, United States (Tosedostat)

Completed
  • Acute Myeloid Leukemia
  • AML
  • Tosedostat
  • Los Angeles, California
  • +20 more
Jun 27, 2012

Healthy Trial in Evansville (CHR-2797)

Unknown status
  • Healthy
  • Evansville, Indiana
    Covance Clinical Research Unit Inc.
Jul 18, 2012

NSCLC Trial in United States (CHR-2797 (tosedostat), erlotinib)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • Beverly Hills, California
  • +6 more
Jun 27, 2012

Acute Myeloid Leukemia Trial in United States (CHR-2797)

Unknown status
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +5 more
Feb 14, 2012

Solid Tumor Trial in Nijmegen, Rotterdam (CHR-2797)

Completed
  • Solid Tumor
  • Nijmegen, Netherlands
  • +1 more
Feb 14, 2012

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Multiple Myeloma Trial in Edinburgh (CHR-2797 (tosedostat): Aminopeptidase

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • CHR-2797 (tosedostat): Aminopeptidase inhibitor
  • Edinburgh, Scotland, United Kingdom
    Nexus Oncology Ltd
Oct 21, 2010

Advanced Solid Tumors Trial (CHR-2797 (tosedostat))

Completed
  • Advanced Solid Tumors
  • CHR-2797 (tosedostat)
  • (no location specified)
Aug 5, 2010